ASX:AYA Artrya (AYA) Stock Price, News & Analysis → See this before next week's Fed meeting (From Stansberry Research) (Ad) Free AYA Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Artrya alerts: Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About ArtryaArtrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.Read More Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. AYA Stock News HeadlinesApril 3, 2024 | finance.yahoo.comIs Artrya (ASX:AYA) In A Good Position To Deliver On Growth Plans?February 18, 2024 | msn.comCompare with Artrya Ltd (AYA)April 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)January 3, 2024 | finance.yahoo.comArtrya Limited (AYA.AX)November 17, 2023 | npr.orgAya BatrawyNovember 3, 2023 | finance.yahoo.comFavourable Signals For Artrya: Numerous Insiders Acquired StockAugust 6, 2022 | finance.yahoo.comWe're Not Very Worried About Artrya's (ASX:AYA) Cash Burn RateAugust 1, 2022 | proactiveinvestors.comArtrya appoints US healthcare leader as non-executive directorApril 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)June 27, 2022 | proactiveinvestors.com.auA theatre of human innovationJune 27, 2022 | finance.yahoo.comARTRYA APPOINTS RENOWNED EXECUTIVE DR JACQUE SOKOLOV AS UNITED STATES ADVISORJune 27, 2022 | finance.yahoo.comArtrya (ASX:AYA) Is In A Good Position To Deliver On Growth PlansSee More Headlines Receive AYA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Artrya and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:AYA CUSIPN/A CIKN/A Webwww.artrya.com Phone61 8 6478 7816FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,560,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-39.26% Return on Assets-23.41% Debt Debt-to-Equity Ratio4.54 Current Ratio11.54 Quick Ratio18.20 Sales & Book Value Annual Sales$197,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.30 per share Price / BookN/AMiscellaneous Outstanding Shares78,650,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.75 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Mathew ReganChief Executive OfficerMr. John Konstantopoulos B.E.Co-Founder and Executive of Commercial & StrategyMr. Mark WainwrightChief Financial OfficerProf. Girish Dwivedi M.D.Chief Scientific OfficerMr. Ted SchwabCo-CEO of Artrya USA IncMr. Kevin Ronald Hart B.Com. (Age 62)B.Comm (Hons), C.A., F.C.A., Company Secretary More ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFAscomOTCMKTS:ACMLFView All CompetitorsInsidersCatherine (Kate) HillBought 250,000 shares on 12/18/2023Total: $37,500.00 ($0.15/share)Catherine (Kate) HillBought 100,000 shares on 5/12/2023Total: $25,700.00 ($0.26/share) This page (ASX:AYA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artrya Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
